Effect of atorvastatin versus placebo on efficacy in patients with diffuse large B-cell lymphoma receiving R-CHOP-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effect of atorvastatin versus placebo on efficacy in patients with diffuse large B-cell lymphoma receiving R-CHOP

Published:2024-02-21 Issue:6 Volume:65 Page:783-788
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Nemec Ronald¹,Scherrer-Crosbie Marielle²,Abramson Jeremy S.¹,Redd Robert³,Gilman Hannah K.⁴,Ho Terry⁴,Wu Jessica⁴,Heemelaar Julius⁴,Neuberg Donna³,Hochberg Ephraim P.¹,Barnes Jeffrey A.¹,Armand Philippe⁵,Jacobsen Eric D.⁵,Jacobson Caron A.⁵,Kim Austin I.⁵,Friedman Robb S.⁶,LaCasce Ann S.⁵,Neilan Tomas G.⁴,Soumerai Jacob D.¹^ORCID

Affiliation:

1. Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA

2. Division of Cardiology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA

3. Department of Data Science, Dana Farber Cancer Institute, Boston, MA, USA

4. Division of Cardiology, Massachusetts General Hospital, Boston, MA, USA

5. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA

6. Division of Medical Oncology, Newton-Wellesley Hospital, Newton, MA, USA

Funder

National Cancer Institute

National Heart, Lung, and Blood Institute

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2024.2317343

Reference16 articles.

1. Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma

2. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

3. Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte

4. Atorvastatin for Anthracycline-Associated Cardiac Dysfunction

5. Statins enhance the chemosensitivity of R-CHOP in diffuse large B-cell lymphoma

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3